T1	Participants 343 427	Prospectively enrolled patients with rectal cancer from October 2007 to October 2008
T2	Participants 828 893	Total of 225 cases with rectal cancer were enrolled in this study
T3	Participants 895 975	There were 110 cases in MSCT and SAA combined group and 115 cases in MSCT group.
T4	Participants 121 136	rectal cancer].
T5	Participants 976 1042	The baseline characteristics was comparable between the two groups
